Annual Shareholders Equity
$12.87 M
-$23.99 M-65.09%
December 31, 2023
Summary
- As of February 8, 2025, RANI annual stockholders equity is $12.87 million, with the most recent change of -$23.99 million (-65.09%) on December 31, 2023.
- During the last 3 years, RANI annual shareholders equity has risen by +$126.20 million (+111.35%).
- RANI annual shareholders equity is now -72.86% below its all-time high of $47.41 million, reached on December 31, 2021.
Performance
RANI Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$3.12 M
+$285.00 K+10.05%
September 30, 2024
Summary
- As of February 8, 2025, RANI quarterly stockholders equity is $3.12 million, with the most recent change of +$285.00 thousand (+10.05%) on September 30, 2024.
- Over the past year, RANI quarterly shareholders equity has increased by +$285.00 thousand (+10.05%).
- RANI quarterly shareholders equity is now -99.62% below its all-time high of $812.49 million, reached on September 30, 2020.
Performance
RANI Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
RANI Shareholders Equity Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -65.1% | +10.1% |
3 y3 years | +111.3% | +10.1% |
5 y5 years | +113.3% | +10.1% |
RANI Shareholders Equity Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -72.9% | at low | -94.2% | +10.1% |
5 y | 5-year | -72.9% | +111.3% | -99.6% | +102.5% |
alltime | all time | -72.9% | +111.3% | -99.6% | +102.5% |
Rani Therapeutics Holdings Shareholders Equity History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $3.12 M(+10.1%) |
Jun 2024 | - | $2.83 M(-61.7%) |
Mar 2024 | - | $7.40 M(-42.5%) |
Dec 2023 | $12.87 M(-65.1%) | $12.87 M(-26.7%) |
Sep 2023 | - | $17.55 M(-27.1%) |
Jun 2023 | - | $24.09 M(-21.6%) |
Mar 2023 | - | $30.72 M(-16.6%) |
Dec 2022 | $36.85 M | $36.85 M(-12.7%) |
Sep 2022 | - | $42.19 M(-11.8%) |
Date | Annual | Quarterly |
---|---|---|
Jun 2022 | - | $47.81 M(-10.4%) |
Mar 2022 | - | $53.38 M(+12.6%) |
Dec 2021 | $47.41 M(-141.8%) | $47.41 M(-7.7%) |
Sep 2021 | - | $51.37 M(-141.5%) |
Jun 2021 | - | -$123.67 M(+4.4%) |
Mar 2021 | - | -$118.47 M(+4.5%) |
Dec 2020 | -$113.34 M(+17.3%) | -$113.34 M(-113.9%) |
Sep 2020 | - | $812.49 M(+2.2%) |
Jun 2020 | - | $795.34 M |
Dec 2019 | -$96.64 M | - |
FAQ
- What is Rani Therapeutics Holdings annual stockholders equity?
- What is the all time high annual shareholders equity for Rani Therapeutics Holdings?
- What is Rani Therapeutics Holdings annual shareholders equity year-on-year change?
- What is Rani Therapeutics Holdings quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Rani Therapeutics Holdings?
- What is Rani Therapeutics Holdings quarterly shareholders equity year-on-year change?
What is Rani Therapeutics Holdings annual stockholders equity?
The current annual shareholders equity of RANI is $12.87 M
What is the all time high annual shareholders equity for Rani Therapeutics Holdings?
Rani Therapeutics Holdings all-time high annual stockholders equity is $47.41 M
What is Rani Therapeutics Holdings annual shareholders equity year-on-year change?
Over the past year, RANI annual stockholders equity has changed by -$23.99 M (-65.09%)
What is Rani Therapeutics Holdings quarterly stockholders equity?
The current quarterly shareholders equity of RANI is $3.12 M
What is the all time high quarterly shareholders equity for Rani Therapeutics Holdings?
Rani Therapeutics Holdings all-time high quarterly stockholders equity is $812.49 M
What is Rani Therapeutics Holdings quarterly shareholders equity year-on-year change?
Over the past year, RANI quarterly stockholders equity has changed by +$285.00 K (+10.05%)